Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - PRE-TAX INCOME
Pre-tax Income APLS - Apellis Pharmaceuticals, Inc.
-526 M
LAST VALUE
15.99%
2 YEAR CAGR
-32.79%
5 YEAR CAGR
-63.06%
10 YEAR CAGR